{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:49:42Z","timestamp":1771066182945,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT186240"],"award-info":[{"award-number":["PJT186240"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022221","name":"SickKids Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022221","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100023930","name":"University of Toronto McLaughlin Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023930","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genome-wide sequencing and genetic matchmaker services are propelling a new era of genotype-driven ascertainment of novel genetic conditions. The degree to which reported phenotype data in discovery-focused studies address informational priorities for clinicians and families is unclear. We identified reports published from 2017 to 2021 in 10 genetics journals of novel Mendelian disorders. We adjudicated the quality and detail of the phenotype data via 46 questions pertaining to six priority domains: (I) Development, cognition, and mental health; (II) Feeding and growth; (III) Medication use and treatment history; (IV) Pain, sleep, and quality of life; (V) Adulthood; and (VI) Epilepsy. For a subset of articles, all subsequent published follow-up case descriptions were identified and assessed in a similar manner. A modified Delphi approach was used to develop consensus reporting guidelines, with input from content experts across four countries. In total, 200 of 3243 screened publications met inclusion criteria. Relevant phenotypic details across each of the 6 domains were rated superficial or deficient in &gt;87% of papers. For example, less than 10% of publications provided details regarding neuropsychiatric diagnoses and \u201cbehavioural issues\u201d, or about the type\/nature of feeding problems. Follow-up reports (<jats:italic>n<\/jats:italic>\u2009=\u200995) rarely contributed this additional phenotype data. In summary, phenotype information relevant to clinical management, genetic counselling, and the stated priorities of patients and families is lacking for many newly described genetic diseases. The PHELIX (PHEnotype LIsting fiX) reporting guideline checklists were developed to improve phenotype reporting in the genomic era.<\/jats:p>","DOI":"10.1038\/s41525-024-00408-w","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T13:01:54Z","timestamp":1712408514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions"],"prefix":"10.1038","volume":"9","author":[{"given":"Ali","family":"AlMail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Jamjoom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vann","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa M.","family":"D\u2019Gama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole S. Y.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-2909","authenticated-orcid":false,"given":"Amy","family":"McTague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-5136","authenticated-orcid":false,"given":"Annapurna","family":"Poduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Wiltrout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"IPCHiP Executive Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-7279","authenticated-orcid":false,"given":"Anne S.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8431-0641","authenticated-orcid":false,"given":"John","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-8199","authenticated-orcid":false,"given":"Lucie","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tess","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Siper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zornitza","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-3126","authenticated-orcid":false,"given":"Jacob A. S.","family":"Vorstman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Diskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Jewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Baribeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-9945","authenticated-orcid":false,"given":"Gregory","family":"Costain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,6]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ajhg.2019.07.011","volume":"105","author":"MJ Bamshad","year":"2019","unstructured":"Bamshad, M. J., Nickerson, D. A. & Chong, J. X. Mendelian gene discovery: fast and furious with no end in sight. Am. J. Hum. Genet. 105, 448\u2013455 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"408_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2019.02.040","volume":"177","author":"KM Boycott","year":"2019","unstructured":"Boycott, K. M. et al. A diagnosis for all rare genetic diseases: the horizon and the next frontiers. Cell 177, 32\u201337 (2019).","journal-title":"Cell"},{"key":"408_CR3","first-page":"659","volume":"43","author":"KM Boycott","year":"2022","unstructured":"Boycott, K. M., Azzariti, D. R., Hamosh, A. & Rehm, H. L. Seven years since the launch of the Matchmaker Exchange: the evolution of genomic matchmaking. Hum. Mutat. 43, 659\u2013667 (2022).","journal-title":"Hum. Mutat."},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajhg.2022.12.004","volume":"110","author":"CM Wilczewski","year":"2023","unstructured":"Wilczewski, C. M. et al. Genotype first: clinical genomics research through a reverse phenotyping approach. Am. J. Hum. Genet 110, 3\u201312 (2023).","journal-title":"Am. J. Hum. Genet"},{"key":"408_CR5","doi-asserted-by":"publisher","unstructured":"Gargano, M. A. et al. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkad1005 (2023).","DOI":"10.1093\/nar\/gkad1005"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"913.e3","DOI":"10.1016\/j.medj.2023.10.003","volume":"4","author":"LC Carmody","year":"2023","unstructured":"Carmody, L. C. et al. The Medical Action Ontology: a tool for annotating and analyzing treatments and clinical management of human disease. Med 4, 913.e3\u2013927.e3 (2023).","journal-title":"Med"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"e0285433","DOI":"10.1371\/journal.pone.0285433","volume":"18","author":"D Danis","year":"2023","unstructured":"Danis, D. et al. Phenopacket-tools: building and validating GA4GH Phenopackets. PLoS ONE 18, e0285433 (2023).","journal-title":"PLoS ONE"},{"key":"408_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ggn2.202200016","volume":"4","author":"MS Ladewig","year":"2023","unstructured":"Ladewig, M. S. et al. GA4GH Phenopackets: a practical introduction. Adv. Genet. 4, 2200016 (2023).","journal-title":"Adv. Genet."},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41587-022-01357-4","volume":"40","author":"JOB Jacobsen","year":"2022","unstructured":"Jacobsen, J. O. B. et al. The GA4GH Phenopacket schema defines a computable representation of clinical data. Nat. Biotechnol. 40, 817\u2013820 (2022).","journal-title":"Nat. Biotechnol."},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/jmedgenet-2019-106111","volume":"56","author":"D Bick","year":"2019","unstructured":"Bick, D., Jones, M., Taylor, S. L., Taft, R. J. & Belmont, J. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. J. Med. Genet. 56, 783\u2013791 (2019).","journal-title":"J. Med. Genet."},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1001\/jama.2020.7671","volume":"323","author":"Australian Genomics Health Alliance Acute Care Flagship","year":"2020","unstructured":"Australian Genomics Health Alliance Acute Care Flagship et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian Public Health Care System. JAMA 323, 2503\u20132511 (2020).","journal-title":"JAMA"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"E1626","DOI":"10.1503\/cmaj.210549","volume":"193","author":"G Costain","year":"2021","unstructured":"Costain, G., Cohn, R. D., Scherer, S. W. & Marshall, C. R. Genome sequencing as a diagnostic test. CMAJ 193, E1626\u2013E1629 (2021).","journal-title":"CMAJ"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"e2018109","DOI":"10.1001\/jamanetworkopen.2020.18109","volume":"3","author":"G Costain","year":"2020","unstructured":"Costain, G. et al. Genome sequencing as a diagnostic test in children with unexplained medical complexity. JAMA Netw. Open 3, e2018109 (2020).","journal-title":"JAMA Netw. Open"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/archdischild-2022-325094","volume":"108","author":"B Haque","year":"2023","unstructured":"Haque, B. et al. Contemporary aetiologies of medical complexity in children: a cohort study. Arch. Dis. Child. 108, 147\u2013149 (2023).","journal-title":"Arch. Dis. Child."},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2788.2011.01510.x","volume":"56","author":"G Costain","year":"2012","unstructured":"Costain, G., Chow, E. W., Ray, P. N. & Bassett, A. S. Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J. Intellect. Disabil. Res. 56, 641\u2013651 (2012).","journal-title":"J. Intellect. Disabil. Res."},{"key":"408_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100831","volume":"25","author":"LDM Pena","year":"2023","unstructured":"Pena, L. D. M. et al. Contributions from medical geneticists in clinical trials of genetic therapies: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100831 (2023).","journal-title":"Genet. Med."},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41591-023-02335-2","volume":"29","author":"JG Gleeson","year":"2023","unstructured":"Gleeson, J. G. et al. Personalized antisense oligonucleotides \u2018for free, for life\u2019 - the n-Lorem Foundation. Nat. Med. 29, 1302\u20131303 (2023).","journal-title":"Nat. Med."},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/gim.2011.17","volume":"14","author":"JH Fanos","year":"2012","unstructured":"Fanos, J. H. New \u201cfirst families\u201d: the psychosocial impact of new genetic technologies. Genet. Med. 14, 189\u2013190 (2012).","journal-title":"Genet. Med."},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/jgc4.1522","volume":"31","author":"W Lee","year":"2022","unstructured":"Lee, W. et al. Genome sequencing among children with medical complexity: what constitutes value from parents\u2019 perspective? J. Genet. Couns. 31, 523\u2013533 (2022).","journal-title":"J. Genet. Couns."},{"key":"408_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1075-8","volume":"14","author":"L Vandeborne","year":"2019","unstructured":"Vandeborne, L., van Overbeeke, E., Dooms, M., De Beleyr, B. & Huys, I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J. Rare Dis. 14, 99 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"408_CR21","doi-asserted-by":"publisher","unstructured":"Diskin, C. et al. Research priorities for children with neurological impairment and medical complexity in high-income countries. Dev. Med. Child Neurol. https:\/\/doi.org\/10.1111\/dmcn.15037 (2021).","DOI":"10.1111\/dmcn.15037"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jhm.13019","volume":"18","author":"KE Nelson","year":"2023","unstructured":"Nelson, K. E. et al. Clinical characteristics of children with severe neurologic impairment: a scoping review. J. Hosp. Med. 18, 65\u201377 (2023).","journal-title":"J. Hosp. Med."},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"e229085","DOI":"10.1001\/jamanetworkopen.2022.9085","volume":"5","author":"PJ Gill","year":"2022","unstructured":"Gill, P. J. et al. Patient, caregiver, and clinician participation in prioritization of research questions in pediatric hospital medicine. JAMA Netw. Open 5, e229085 (2022).","journal-title":"JAMA Netw. Open"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1176\/appi.ajp.2021.21040432","volume":"179","author":"S Jacquemont","year":"2022","unstructured":"Jacquemont, S. et al. Genes To Mental Health (G2MH): a framework to map the combined effects of rare and common variants on dimensions of cognition and psychopathology. Am. J. Psychiatry 179, 189\u2013203 (2022).","journal-title":"Am. J. Psychiatry"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.ajhg.2022.07.003","volume":"109","author":"Commission on Novel Technologies for Neurodevelopmental Copy Number Variants.","year":"2022","unstructured":"Commission on Novel Technologies for Neurodevelopmental Copy Number Variants. Neurodevelopmental copy-number variants: a roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact. Am. J. Hum. Genet. 109, 1353\u20131365 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/cge.13882","volume":"99","author":"C Hanly","year":"2021","unstructured":"Hanly, C., Shah, H., Au, P. Y. B. & Murias, K. Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: a scoping review. Clin. Genet. 99, 335\u2013346 (2021).","journal-title":"Clin. Genet."},{"key":"408_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104531","volume":"65","author":"A McTague","year":"2022","unstructured":"McTague, A. et al. Defining causal variants in rare epilepsies: an essential team effort between biomedical scientists, geneticists and epileptologists. Eur. J. Med. Genet. 65, 104531 (2022).","journal-title":"Eur. J. Med. Genet."},{"key":"408_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/cge.14349","volume":"104","author":"P Perlman","year":"2023","unstructured":"Perlman, P. et al. Support to caregivers who have received genetic information about neurodevelopmental and psychiatric vulnerability in their young children: a narrative review. Clin. Genet. 104, 163\u2013173 (2023).","journal-title":"Clin. Genet."},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41431-022-01181-z","volume":"30","author":"DA Baribeau","year":"2022","unstructured":"Baribeau, D. A. et al. Developmental implications of genetic testing for physical indications. Eur. J. Hum. Genet. 30, 1297\u20131300 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ejhg.2017.65","volume":"25","author":"F Altmuller","year":"2017","unstructured":"Altmuller, F. et al. Genotype and phenotype spectrum of NRAS germline variants. Eur. J. Hum. Genet. 25, 823\u2013831 (2017).","journal-title":"Eur. J. Hum. Genet."},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jmg.2007.054460","volume":"45","author":"CM Armour","year":"2008","unstructured":"Armour, C. M. & Allanson, J. E. Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. J. Med. Genet. 45, 249\u2013254 (2008).","journal-title":"J. Med. Genet."},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ajmg.a.30984","volume":"138","author":"AS Bassett","year":"2005","unstructured":"Bassett, A. S. et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. A 138, 307\u2013313 (2005).","journal-title":"Am. J. Med. Genet. A"},{"key":"408_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/gim.2014.175","volume":"17","author":"WL Fung","year":"2015","unstructured":"Fung, W. L. et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet. Med. 17, 599\u2013609 (2015).","journal-title":"Genet. Med."},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1503\/cmaj.071300","volume":"178","author":"RK Kapadia","year":"2008","unstructured":"Kapadia, R. K. & Bassett, A. S. Recognizing a common genetic syndrome: 22q11.2 deletion syndrome. CMAJ 178, 391\u2013393 (2008).","journal-title":"CMAJ"},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1542\/peds.2013-4301","volume":"134","author":"SA Kidd","year":"2014","unstructured":"Kidd, S. A. et al. Fragile X syndrome: a review of associated medical problems. Pediatrics 134, 995\u20131005 (2014).","journal-title":"Pediatrics"},{"key":"408_CR36","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1073\/pnas.91.11.4997","volume":"91","author":"JR Korenberg","year":"1994","unstructured":"Korenberg, J. R. et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl Acad. Sci. USA 91, 4997\u20135001 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"408_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jmg.2009.075937","volume":"47","author":"VF Mautner","year":"2010","unstructured":"Mautner, V. F. et al. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J. Med. Genet. 47, 623\u2013630 (2010).","journal-title":"J. Med. Genet."},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","volume":"49","author":"E Pasmant","year":"2012","unstructured":"Pasmant, E., Vidaud, M., Vidaud, D. & Wolkenstein, P. Neurofibromatosis type 1: from genotype to phenotype. J. Med. Genet. 49, 483\u2013489 (2012).","journal-title":"J. Med. Genet."},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s41436-021-01183-0","volume":"23","author":"WK Chung","year":"2021","unstructured":"Chung, W. K. et al. Genomic medicine implementation protocols in the PhenX Toolkit: tools for standardized data collection. Genet. Med. 23, 1783\u20131788 (2021).","journal-title":"Genet. Med."},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ajhg.2020.02.015","volume":"106","author":"TY Tan","year":"2020","unstructured":"Tan, T. Y. et al. Bi-allelic ADARB1 variants associated with microcephaly, intellectual disability, and seizures. Am. J. Hum. Genet. 106, 467\u2013483 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"408_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41436-020-01076-8","volume":"23","author":"AM Muir","year":"2021","unstructured":"Muir, A. M. et al. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia. Genet. Med. 23, 881\u2013887 (2021).","journal-title":"Genet. Med."},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajhg.2018.11.017","volume":"104","author":"TN Khan","year":"2019","unstructured":"Khan, T. N. et al. Mutations in NCAPG2 cause a severe neurodevelopmental syndrome that expands the phenotypic spectrum of condensinopathies. Am. J. Hum. Genet. 104, 94\u2013111 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"408_CR43","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41436-021-01260-4","volume":"23","author":"M Iqbal","year":"2021","unstructured":"Iqbal, M. et al. Biallelic variants in PCDHGC4 cause a novel neurodevelopmental syndrome with progressive microcephaly, seizures, and joint anomalies. Genet. Med. 23, 2138\u20132149 (2021).","journal-title":"Genet. Med."},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41588-021-00886-z","volume":"53","author":"MA Cousin","year":"2021","unstructured":"Cousin, M. A. et al. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat. Genet. 53, 1006\u20131021 (2021).","journal-title":"Nat. Genet."},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41431-019-0380-y","volume":"27","author":"T Harel","year":"2019","unstructured":"Harel, T. et al. Homozygous stop-gain variant in LRRC32, encoding a TGFbeta receptor, associated with cleft palate, proliferative retinopathy, and developmental delay. Eur. J. Hum. Genet. 27, 1315\u20131319 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/acn3.528","volume":"5","author":"T Akita","year":"2018","unstructured":"Akita, T. et al. De novo variants in CAMK2A and CAMK2B cause neurodevelopmental disorders. Ann. Clin. Transl. Neurol. 5, 280\u2013296 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"794008","DOI":"10.3389\/fphar.2022.794008","volume":"13","author":"BK Dwyer","year":"2022","unstructured":"Dwyer, B. K., Veenma, D. C. M., Chang, K., Schulman, H. & Van Woerden, G. M. Case report: Developmental delay and acute neuropsychiatric episodes associated with a de novo mutation in the CAMK2B gene (c.328G>A p.Glu110Lys). Front. Pharm. 13, 794008 (2022).","journal-title":"Front. Pharm."},{"key":"408_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00900-3","volume":"13","author":"I Mannucci","year":"2021","unstructured":"Mannucci, I. et al. Genotype-phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders. Genome Med. 13, 90 (2021).","journal-title":"Genome Med."},{"key":"408_CR49","volume":"8","author":"ME Romero-Ibarguengoitia","year":"2020","unstructured":"Romero-Ibarguengoitia, M. E. et al. Comparison of genetic variants and manifestations of OTUD6B-related disorder: the first Mexican case. J. Investig. Med. High. Impact Case Rep. 8, 2324709620957777 (2020).","journal-title":"J. Investig. Med. High. Impact Case Rep."},{"key":"408_CR50","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/hmg\/ddy052","volume":"27","author":"T Mizuguchi","year":"2018","unstructured":"Mizuguchi, T. et al. Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders. Hum. Mol. Genet. 27, 1421\u20131433 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/hmg\/ddx435","volume":"27","author":"C Toro","year":"2018","unstructured":"Toro, C. et al. A recurrent de novo missense mutation in UBTF causes developmental neuroregression. Hum. Mol. Genet. 27, 691\u2013705 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"408_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-0038-1676288","volume":"50","author":"L Sedlackova","year":"2019","unstructured":"Sedlackova, L. et al. UBTF mutation causes complex phenotype of neurodegeneration and severe epilepsy in childhood. Neuropediatrics 50, 57\u201360 (2019).","journal-title":"Neuropediatrics"},{"key":"408_CR53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cge.13933","volume":"99","author":"A Cospain","year":"2021","unstructured":"Cospain, A. et al. Skraban-Deardorff syndrome: six new cases of WDR26-related disease and expansion of the clinical phenotype. Clin. Genet. 99, 732\u2013739 (2021).","journal-title":"Clin. Genet."},{"key":"408_CR54","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ajmg.a.62157","volume":"185","author":"L Pavinato","year":"2021","unstructured":"Pavinato, L. et al. Expanding the clinical phenotype of the ultra-rare Skraban-Deardorff syndrome: two novel individuals with WDR26 loss-of-function variants and a literature review. Am. J. Med. Genet. A 185, 1712\u20131720 (2021).","journal-title":"Am. J. Med. Genet. A"},{"key":"408_CR55","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/ajmg.a.61731","volume":"182","author":"MT Carminho-Rodrigues","year":"2020","unstructured":"Carminho-Rodrigues, M. T. et al. Complex movement disorder in a patient with heterozygous YY1 mutation (Gabriele-de Vries syndrome). Am. J. Med. Genet. A 182, 2129\u20132132 (2020).","journal-title":"Am. J. Med. Genet. A"},{"key":"408_CR56","doi-asserted-by":"publisher","first-page":"e1000217","DOI":"10.1371\/journal.pmed.1000217","volume":"7","author":"D Moher","year":"2010","unstructured":"Moher, D., Schulz, K. F., Simera, I. & Altman, D. G. Guidance for developers of health research reporting guidelines. PLoS Med. 7, e1000217 (2010).","journal-title":"PLoS Med."},{"key":"408_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108198","volume":"122","author":"C Juando-Prats","year":"2021","unstructured":"Juando-Prats, C. et al. DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: perspectives, needs, and opportunities for clinical research. Epilepsy Behav. 122, 108198 (2021).","journal-title":"Epilepsy Behav."},{"key":"408_CR58","first-page":"42","volume":"8","author":"C Collins","year":"2016","unstructured":"Collins, C. Phenotype with a side of genotype, please: Patients, parents and priorities in rare genetic disease. Appl. Transl. Genom. 8, 42\u201344 (2016).","journal-title":"Appl. Transl. Genom."},{"key":"408_CR59","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/humu.22347","volume":"34","author":"M Girdea","year":"2013","unstructured":"Girdea, M. et al. PhenoTips: patient phenotyping software for clinical and research use. Hum. Mutat. 34, 1057\u20131065 (2013).","journal-title":"Hum. Mutat."},{"key":"408_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-56","volume":"8","author":"LG Biesecker","year":"2010","unstructured":"Biesecker, L. G. An introduction to standardized clinical nomenclature for dysmorphic features: the Elements of Morphology project. BMC Med. 8, 56 (2010).","journal-title":"BMC Med."},{"key":"408_CR61","volume":"3","author":"AM Elliott","year":"2022","unstructured":"Elliott, A. M. et al. Genome-wide sequencing and the clinical diagnosis of genetic disease: the CAUSES study. HGG Adv. 3, 100108 (2022).","journal-title":"HGG Adv."},{"key":"408_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41525-018-0056-5","volume":"3","author":"CC Mak","year":"2018","unstructured":"Mak, C. C. et al. Exome sequencing for paediatric-onset diseases: impact of the extensive involvement of medical geneticists in the diagnostic odyssey. NPJ Genom. Med. 3, 19 (2018).","journal-title":"NPJ Genom. Med."},{"key":"408_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jamaneurol.2022.0067","volume":"79","author":"SU Morton","year":"2022","unstructured":"Morton, S. U. et al. Multicenter consensus approach to evaluation of neonatal hypotonia in the genomic era: a review. JAMA Neurol. 79, 405\u2013413 (2022).","journal-title":"JAMA Neurol."},{"key":"408_CR64","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1474-4422(23)00246-6","volume":"22","author":"AM D\u2019Gama","year":"2023","unstructured":"D\u2019Gama, A. M. et al. Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. Lancet Neurol. 22, 812\u2013825 (2023).","journal-title":"Lancet Neurol."},{"key":"408_CR65","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/hmg\/ddac018","volume":"31","author":"T Levy","year":"2022","unstructured":"Levy, T. et al. CHAMP1 disorder is associated with a complex neurobehavioral phenotype including autism, ADHD, repetitive behaviors and sensory symptoms. Hum. Mol. Genet. 31, 2582\u20132594 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"408_CR66","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/ddab280","volume":"31","author":"T Levy","year":"2022","unstructured":"Levy, T. et al. Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium. Hum. Mol. Genet. 31, 625\u2013637 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"408_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-021-00431-z","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang, L. et al. Prospective and detailed behavioral phenotyping in DDX3X syndrome. Mol. Autism 12, 36 (2021).","journal-title":"Mol. Autism"},{"key":"408_CR68","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/gim.2012.66","volume":"14","author":"NJ Butcher","year":"2012","unstructured":"Butcher, N. J. et al. Functional outcomes of adults with 22q11.2 deletion syndrome. Genet. Med. 14, 836\u2013843 (2012).","journal-title":"Genet. Med."},{"key":"408_CR69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41436-019-0603-1","volume":"22","author":"SL Malecki","year":"2020","unstructured":"Malecki, S. L. et al. A genetic model for multimorbidity in young adults. Genet. Med. 22, 132\u2013141 (2020).","journal-title":"Genet. Med."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-024-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-024-00408-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-024-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T14:05:32Z","timestamp":1712412332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-024-00408-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,6]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1038\/s41525-024-00408-w","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,6]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.B. has received research funds from MapLight Therapeutics. K.W. has consulted for Stoke Therapeutics. J.A.S.V. has served as a consultant for NoBias Therapeutics Inc. and has received speaker fees for Henry Stewart Talks Ltd. These relationships did not influence content of this manuscript but are disclosed for potential future considerations. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}